Patient preference studies are not the standard market research study. They are multi phase extended endeavors. One step builds on another; from the first, all steps impact the later and final benefit report results.

Although they follow mostly standardized format procedural steps, specifically crafting each single step is both complex and tricky.

The term strategic truly fits here to ensure reliable success. They present a much higher degree of research responsibility. The entire research is as well highly scrutinized for its validity e.g. by government entities.

Preference studies require an informed, yet empathic embracing of the very condition of patient-citizens. They delve into the ever-existing range of contradictions, conflicts and common logics.

Understanding patients in their illness related, world and life situation takes professional psychological knowhow. Patients don’t perceive all the whys and hows of their condition and therapy. An in-depth, extended morphological approach explains experiences, relevant illness life stories and their structural relevance. It takes this analytical approach to explains what happens to a therapy actually applied in real life.

Patient preference studies require academic expert advice or co-conducting with the companies for applicable procedural standards.
Needed is the combining of competences in different areas. These include:

1. Assess the relevant patient illness ecosystem (incl. patients’ motivators, hopes, fears, habits and related needs).
2. Developing an attribute level matrix and designing the experiment with the adequate statistical instruments.
3. Utilizing pharmaceutical know-how, overall strategic analysis and advanced qualitative and quantitative competences.

Our cross-area team carefully prepares and lays out the possible research scenarios for our clients.